[177Lu]Lu-DOTA-HBED-bisphosphonate

N/A

Report date: 2025/11/28 16:58:31
NME

Base Information

Drug Name[177Lu]Lu-DOTA-HBED-bisphosphonate
Drug Alias Name[177Lu]Lu-DOTA-HBED-CC-bisphosphonate[177Lu]Lu-1[177Lu]Lu-P15-073
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4] 
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Normal UniversityShenzhen Bay LaboratoryFive Eleven Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesFive Eleven Pharma IncShenzhen Bay LaboratoryBeijing Normal University
Inactive CompaniesN/A
Active IndicationsBone metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A